been selling properties<\/a> in advance of and following the acquisition announcement, and it is widely believed the company will shed more assets to avoid regulatory issues in key markets such as Atlantic City, N.J. and Las Vegas, among others.<\/p>\nInside IRadimed<\/h2>\n
\u201cIRadimed is a leader in MRI patient care, with vast experience in MRI innovation,\u201d according to the company’s web site. \u201cRoger Susi, our president and CEO, is the founder of Invivo Research, where he pioneered the world\u2019s first and best-selling MRI patient vital signs monitoring brand, as well as founding IRadimed Corporation, the producer of the world\u2019s first and best-selling non-magnetic MRI infusion pumps and patient monitors.\u201d<\/p>\n
The company has a market capitalization of nearly $215 million, putting it in micro-cap territory. Eldorado’s SEC filing notes that the aforementioned insiders received subpoenas in May, but it does not say when the executives allegedly transacted in IRadimed stock. Nor does the filing use the phrase \u201cinsider trading.\u201d<\/p>\n
From the start of this year through the end of April, shares of Iradimed gained about 50 percent before shedding nearly a third of their value just in the month of May<\/strong>. The stock closed at $18.82 today.<\/p>\n","protected":false},"excerpt":{"rendered":"Eldorado Resorts CEO Tom Reeg, another high-ranking executive at the regional gaming company, and two of its board members are being investigated by the Securities and Exchange Commission (SEC) for trades in the tiny medical device manufacturer IRadimed Corp. (NASDAQ:IRMD). Eldorado is in the process of acquiring Caesars Entertainment for $17.3 billion, a transaction that […]<\/p>\n","protected":false},"author":46,"featured_media":114021,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[33810,60],"tags":[],"acf":[],"yoast_head":"\n
Some Eldorado Execs, Including CEO Reeg, Are Under SEC Investigation<\/title>\n\n\n\n\n\n\n\n\n\n\n\n\n\t\n\t\n\t\n\n\n\n\n\n\t\n\t\n\t\n